PGC‐1α inhibits polyamine metabolism in Cyclin E1‐driven ovarian cancer
Abstract Aim Cyclin E1‐driven ovarian cancer (OvCa) is characterized with metabolic shift. In this study, we aim to pinpoint the metabolic pathway altered and assess its therapeutic potential. Methods In silico reproduction of TCGA ovarian cancer dataset and functional annotation using GSEA was perf...
Main Authors: | Ting Guo, Bin Li, Chao Gu, Xiuying Chen, Mengxin Han, Xiaocheng Liu, Congjian Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-12-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2637 |
Similar Items
-
Combined CCNE1 high‐level amplification and overexpression is associated with unfavourable outcome in tubo‐ovarian high‐grade serous carcinoma
by: Angela MY Chan, et al.
Published: (2020-10-01) -
A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer
by: Johannes F. Fahrmann, et al.
Published: (2021-02-01) -
Digital pathology-based study of cell- and tissue-level morphologic features in serous borderline ovarian tumor and high-grade serous ovarian cancer
by: Jun Jiang, et al.
Published: (2021-01-01) -
CCNE1 amplification among metastatic sites in patients with gynecologic high-grade serous carcinoma
by: Benjamin Margolis, et al.
Published: (2021-08-01) -
Asparagine Synthetase and Filamin A Have Different Roles in Ovarian Cancer
by: Liang Zeng, et al.
Published: (2019-10-01)